Last reviewed · How we verify
NCT06189768
A Study on Pigmentation Disorders in Children
trial in Hyperpigmentation in 299 participants. Completed in 1 June 2021.
1 June 2021
Quick facts
| Lead sponsor | Nepal Health Research Council |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 299 |
| Start date | 1 January 2020 |
| Primary completion | 1 June 2021 |
| Estimated completion | 1 June 2021 |
| Sites | 1 location across Nepal |
Conditions studied
- Hyperpigmentation — all drugs for Hyperpigmentation →
- Pediatric Dermatology — all drugs for Pediatric Dermatology →
Sponsor
Nepal Health Research Council
Who can join
Under 15, any sex, with Hyperpigmentation or Pediatric Dermatology. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The descriptive cross-sectional study was undertaken at Kanti Children's Hospital during the period from January 2020 to June 2021. Ethical approval for the study was obtained from the Institutional Review Board of Kanti Children's Hospital (IRB-KCH). The refence number is 59/2020-021. The study focused on children with hyperpigmentation disorders presenting at the Dermatology Outpatient Department of Kanti Children's Hospital.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT06189768
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Hyperpigmentation
Currently open trials in the same condition.
- NCT07162623 — Clinical Study to Assess Safety, Efficacy and In-Use Tolerability of Oziva Bioactive Gluta Fizzy Effervescent Tablets on · NA · active not recruiting
- NCT07067879 — The Effectiveness of a Novel Lip Product Containing Caulerpa Lentillifera Extract for Reducing Lip Hyperpigmentation · NA · recruiting
- NCT06349447 — Pilot Study of LED for PIE and PIH · NA · recruiting
- NCT07067515 — Effectiveness of Omega-3 Poly Unsaturated Fatty Acids on The Treatment of Gingival Hyperpigmentation · Phase 1, PHASE2 · active not recruiting
Other Nepal Health Research Council trials
Trials by the same sponsor.
- NCT05259735 — A Clinical Guideline-based Management of Type-2 Diabetes by Ayurvedic Practitioners in Nepal · NA · completed
- NCT05378438 — Impact of Microbe Literacy Initiative on Improved Vaccine Uptake in Peri-urban Slum Areas in Kathmandu, Nepal · NA · unknown
- NCT04733651 — Study to Investigate the Clinical Efficacy of Isoquercetin in Patients With COVID-19 · Phase 2 · unknown
- NCT04694612 — Efficacy of Favipiravir in Treatment of Mild & Moderate COVID-19 Infection in Nepal · Phase 3 · unknown
- NCT04669990 — Remdesivir and Convalescent Plasma Therapy for Treatment of COVID-19 Infection in Nepal : A Registry Study · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06189768 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Nepal Health Research Council
- Last refreshed: 8 January 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06189768.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing